N/A Completed N=2,738

Adherence to New Oral Anticoagulation Therapy in Turkey

Atrial Fibrillation

Source: ClinicalTrials.gov NCT02480920 ↗

Enrolled (actual)

2,738

Serious AEs

25.1%

Results posted

Jan 2019

Primary outcomePrimary: Compliance of NOACs in Turkish Population — 1342; 1036 Participants

Summary

This study will compose a national database of drug adherence and investigate the factors that affect drug adherence in patients taking new oral anticoagulation therapy in Turkish Population.

Outcome Measures

Outcome	Result	p-value
PRIMARY Compliance of NOACs in Turkish Population	1342; 1036	—

Eligibility Criteria

Inclusion Criteria

Patients >18 years old
Outpatients using a NOAC for at least 3 months duration, with a primary diagnosis of new-onset, non-valvular atrial fibrillation
Patients signed patient informed sheet and informed consent form

Exclusion Criteria

Patients under 18 years old
Patients refused to sign informed consent form

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02480920). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.